Dr. Tanghetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5601 J St
Sacramento, CA 95819Phone+1 916-454-5922Fax+1 916-454-2156
Education & Training
- Lahey ClinicResidency, Dermatology, 1979 - 1980
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1978 - 1979
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1977 - 1978
- University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1976 - 1977
- David Geffen School of Medicine at UCLAClass of 1976
Certifications & Licensure
- CA State Medical License 1977 - 2026
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris Start of enrollment: 2014 Sep 01
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
- Post Market Usability Evaluation Of The PicoSure Pro Device Start of enrollment: 2021 Oct 21
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 17 citationsEfficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study...Linda Stein Gold, Hilary Baldwin, Leon H Kircik, Jonathan S. Weiss, David M. Pariser
American Journal of Clinical Dermatology. 2021-10-21 - 110 citationsThe role of inflammation in the pathology of acne.Emil Tanghetti
The Journal of Clinical and Aesthetic Dermatology. 2013-09-01 - 3 citationsTriple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.Lawrence F Eichenfield, Linda Stein Gold, Leon H Kircik, William P Werschler, Kenneth Beer
Pediatric Dermatology. 2023-03-22
Press Mentions
- FDA Approves Laser System for Long Term Treatment of Inflammatory AcneOctober 20th, 2024
- Ortho Dermatologics Launches Arazlo Lotion in the USJune 29th, 2020
- Top Plastic Surgeons Kortesis and Bharti Join Cartessa Aesthetics' Medical Advisory BoardFebruary 3rd, 2020
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: